These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32219880)

  • 1. Oridonin ameliorates carbon tetrachloride-induced liver fibrosis in mice through inhibition of the NLRP3 inflammasome.
    Liu D; Qin H; Yang B; Du B; Yun X
    Drug Dev Res; 2020 Jun; 81(4):526-533. PubMed ID: 32219880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
    Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
    Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saikosaponin-d protects against liver fibrosis by regulating the estrogen receptor-β/NLRP3 inflammasome pathway.
    Lin L; Zhou M; Que R; Chen Y; Liu X; Zhang K; Shi Z; Li Y
    Biochem Cell Biol; 2021 Oct; 99(5):666-674. PubMed ID: 33974808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelargonidin ameliorates CCl
    Shi YS; Li XX; Li HT; Zhang Y
    Food Funct; 2020 Jun; 11(6):5156-5165. PubMed ID: 32432601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice.
    Inzaugarat ME; Johnson CD; Holtmann TM; McGeough MD; Trautwein C; Papouchado BG; Schwabe R; Hoffman HM; Wree A; Feldstein AE
    Hepatology; 2019 Feb; 69(2):845-859. PubMed ID: 30180270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria-targeted reactive oxygen species blockor SS-31 blocks hepatic stellate cell activation and alleviates hepatic fibrosis by regulating NLRP3 inflammasomes.
    Liu L; Wei Y; Xie N; Cai H; Lin Y
    Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):183-188. PubMed ID: 38430023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs.
    Ge S; Yang W; Chen H; Yuan Q; Liu S; Zhao Y; Zhang J
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydromevalonolactone ameliorates liver fibrosis and inflammation by repressing activation of NLRP3 inflammasome.
    Niu WX; Bao YY; Zhang N; Lu ZN; Ge MX; Li YM; Li Y; Chen MH; He HW
    Bioorg Chem; 2022 Oct; 127():105971. PubMed ID: 35749855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of aldosterone in the activation of primary mice hepatic stellate cell and liver fibrosis via NLRP3 inflammasome.
    Li Y; Zhang Y; Chen T; Huang Y; Zhang Y; Geng S; Li X
    J Gastroenterol Hepatol; 2020 Jun; 35(6):1069-1077. PubMed ID: 31860730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.
    Yi HS; Eun HS; Lee YS; Jung JY; Park SH; Park KG; Choi HS; Suh JM; Jeong WI
    PLoS One; 2015; 10(5):e0127946. PubMed ID: 26024318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.
    Bohanon FJ; Wang X; Graham BM; Ding C; Ding Y; Radhakrishnan GL; Rastellini C; Zhou J; Radhakrishnan RS
    J Surg Res; 2015 Dec; 199(2):441-9. PubMed ID: 26409288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of NLRP3 inflammasomes in mouse hepatic stellate cells during Schistosoma J. infection.
    Meng N; Xia M; Lu YQ; Wang M; Boini KM; Li PL; Tang WX
    Oncotarget; 2016 Jun; 7(26):39316-39331. PubMed ID: 27322427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation.
    Feng S; Xie X; Li J; Xu X; Chen C; Zou G; Lin G; Huang T; Hu R; Ran T; Han L; Zhang Q; Li Y; Zhao X
    Hepatol Int; 2024 Jun; 18(3):1040-1052. PubMed ID: 38172440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oridonin alleviates d-GalN/LPS-induced acute liver injury by inhibiting NLRP3 inflammasome.
    Zhang T; Chen Y; Zhan Z; Mao Z; Wen Y; Liu S; Tang L
    Drug Dev Res; 2021 Jun; 82(4):575-580. PubMed ID: 33377532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP3 inflammasome inhibition decreases
    Lu Y; Liu J; Tang W; Zhang H
    Infect Immun; 2024 Oct; 92(10):e0005524. PubMed ID: 39158264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
    Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
    Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice.
    Wu Y; Li Z; Xiu AY; Meng DX; Wang SN; Zhang CQ
    Drug Des Devel Ther; 2019; 13():2667-2676. PubMed ID: 31534314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-liver fibrosis effect of Tibetan medicine (Qiwei Tiexie capsule) is related to the inhibition of NLRP3 inflammasome activation in vivo and in vitro.
    Wang S; Ye F; Ren Q; Sun S; Xia W; Wang Z; Guo H; Li H; Zhang S; Lowe S; Chen M; Du Q; Weihong Li
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117283. PubMed ID: 37827298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species.
    Zhao Y; Wang Z; Feng D; Zhao H; Lin M; Hu Y; Zhang N; Lv L; Gao Z; Zhai X; Tian X; Yao J
    Theranostics; 2019; 9(5):1510-1522. PubMed ID: 30867846
    [No Abstract]   [Full Text] [Related]  

  • 20. ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model.
    Schuster-Gaul S; Geisler LJ; McGeough MD; Johnson CD; Zagorska A; Li L; Wree A; Barry V; Mikaelian I; Jih LJ; Papouchado BG; Budas G; Hoffman HM; Feldstein AE
    JCI Insight; 2020 Jan; 5(2):. PubMed ID: 31996485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.